Skip To Main Content
Benjamin McDonald on Muck Rack

Benjamin McDonald

As seen in: Gay Times, HCP Live, Telegraph Herald, Gonzaga Bulletin, Manchester Press, The Light Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Benjamin

Contact Benjamin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Advancing Gastroenterology from the Frontlines of Patient Care

|
By Russell Cohen, Benjamin McDonald, Benjamin Mcdonald
| consultantlive.com
2026 Media Day with UChicago Medicine - Episode 4 Published on: , Discover how new IBD therapies, combo drugs, and microbiome research aim to predict response, prevent Crohn’s complications, and expand trial options. Therapeutic innovation in gastroenterology has accelerated over the past decade, reshaping how clinicians evaluate treatment response, define success, and identify unmet needs across inflammatory and metabolic diseases.
Open in Who Shared View Duplicates (2) Issue with article?

Keeping Pace with Advances in Gastroenterology, With Benjamin McDonald, MD, at UChicago Medicine

|
By Russell Cohen, Benjamin McDonald, Benjamin Mcdonald
| consultantlive.com
2026 Media Day with UChicago Medicine - Episode 3 Published on: , Discover how intestinal ultrasound and biomarkers help spot hidden IBD inflammation, guiding faster treat-to-target decisions beyond endoscopy. Inflammatory bowel disease (IBD) management increasingly requires clinicians to reconcile patient-reported symptoms with objective markers of inflammation, a dynamic that continues to evolve as diagnostic tools and therapeutic targets advance.
Open in Who Shared Issue with article?

UChicago Advances IBD Trials With Focus on Microbiome and Access

|
By Russell Cohen, Benjamin McDonald, Benjamin Mcdonald
| consultantlive.com
2026 Media Day with UChicago Medicine - Episode 2 Published on: , Explore emerging IBD treatments—TL1A blockers, microRNA, stem cells—and new small-bowel imaging, plus team-based care improving access. Clinical trial innovation in inflammatory bowel disease (IBD) increasingly reflects a dual mandate: advancing novel therapeutics while ensuring research populations reflect the patients seen in everyday practice.
Open in Who Shared View Duplicates (2) Issue with article?
See all 22 licensed articles (26 Total)